Literature DB >> 12460930

A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction.

Andries Zijlstra1, Rebecca Mellor, Giano Panzarella, Ronald T Aimes, John D Hooper, Natalia D Marchenko, James P Quigley.   

Abstract

A quantitative assessment of rate-limiting steps in metastasis has always been challenging because of the difficulty of detecting small tumor cell populations. We have developed a highly sensitive assay for monitoring the metastatic dissemination of human tumor cells in the chick embryo and used this assay to investigate the relative efficacy of sequential stages in the metastatic cascade for two malignant human tumor cells lines, HEp3 and HT1080. This assay is based on the real-time PCR amplification of human alu sequences and exhibits a high sensitivity (25 cells/lung) with a large linear range (50-100,000 cell/lung). The assay is optimized for a high number of replicate in vivo assays (50-100 animals/assay) and can be applied in both experimental and spontaneous metastasis models. Using quantitative alu PCR, we determined that HEp3 spontaneously metastasizes very efficiently and rapidly, generating secondary growth in the lung exceeding 1-2 x 10(4) cells/lung in 7 days. In contrast, spontaneous HT1080 metastasis is 50-100-fold less efficient, resulting in only 200-400 cells/lung in 7 days. By taking advantage of the sensitivity and specificity of the real-time alu PCR assay we were also able to quantitatively assess multiple steps in metastasis including intravasation, arrest of tumor cells in secondary organs of the embryo, and the initial growth and expansion of the arrested tumor cells. A comparative analysis of HEp3 and HT1080 metastasis demonstrates that the relatively low-to-moderate metastatic rate of HT1080 is caused by two distinct deficiencies, an 8-10-fold lower rate of intravasation and a delayed onset of HT1080 growth expansion in the secondary organ. Thus, a very facile metastasis model system coupled with the sensitive, real-time PCR-based assay allows for the identification and quantification of rate-limiting steps in the metastatic cascade for select human tumor cell lines.

Entities:  

Mesh:

Year:  2002        PMID: 12460930

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  92 in total

1.  Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.

Authors:  C Hope Heath; Nicholas L Deep; Larissa Sweeny; Kurt R Zinn; Eben L Rosenthal
Journal:  Ann Surg Oncol       Date:  2012-06-06       Impact factor: 5.344

2.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

3.  Visualizing extravasation dynamics of metastatic tumor cells.

Authors:  Konstantin Stoletov; Hisashi Kato; Erin Zardouzian; Jonathan Kelber; Jing Yang; Sanford Shattil; Richard Klemke
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

4.  The Chicken Egg Chorioallantoic Membrane (CAM) Model as an In Vivo Method for the Investigation of the Invasion and Metastasis Cascade of Malignant Tumor Cells.

Authors:  Jörg H Leupold; Nitin Patil; Heike Allgayer
Journal:  Methods Mol Biol       Date:  2021

5.  Mechanisms of tumor cell extravasation in an in vitro microvascular network platform.

Authors:  Michelle B Chen; Jordan A Whisler; Jessie S Jeon; Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2013-10       Impact factor: 2.192

6.  The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151.

Authors:  Andries Zijlstra; John Lewis; Bernard Degryse; Heidi Stuhlmann; James P Quigley
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

7.  Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR.

Authors:  Wentao Deng; Sarah L McLaughlin; David J Klinke
Journal:  Analyst       Date:  2017-08-07       Impact factor: 4.616

8.  Role of connexins in metastatic breast cancer and melanoma brain colonization.

Authors:  Konstantin Stoletov; Jan Strnadel; Erin Zardouzian; Masashi Momiyama; Frederick D Park; Jonathan A Kelber; Donald P Pizzo; Robert Hoffman; Scott R VandenBerg; Richard L Klemke
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

9.  SCUBE3 regulation of early lung cancer angiogenesis and metastatic progression.

Authors:  Cheng-Hung Chou; Yi-Fang Cheng; Tiing Yee Siow; Amit Kumar; Konan Peck; Chen Chang
Journal:  Clin Exp Metastasis       Date:  2013-02-19       Impact factor: 5.150

10.  Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.

Authors:  Swadesh K Das; Sujit K Bhutia; Upneet K Sokhi; Belal Azab; Zhao-Zhong Su; Habib Boukerche; Talha Anwar; Erika L Moen; Devasis Chatterjee; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2012-10-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.